TITLE

Radiological findings in cyclical administration of intravenous pamidronate in children with osteoporosis

AUTHOR(S)
Onwuneme, C.
PUB. DATE
December 2007
SOURCE
Archives of Disease in Childhood;Dec2007, Vol. 92 Issue 12, p1087
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Case studies of a 5-year-old boy with moderately severe osteogenesis imperfecta and spontaneous fractures and a 16-year-old boy with camptodactyly coxavara arthropathy pericarditis syndrome and osteoporosis with associated spontaneous fractures are presented. The 5-year-old boy was treated with serial courses of intravenous pamidronate. While, the 16-year-old had undergone several courses of intravenous pamidronate a radiograph of his knee showed a pattern of parallel dense metaphyseal lines.
ACCESSION #
28024416

 

Related Articles

  • Cathepsin K Inhibitors: A Novel Target for Osteoporosis Therapy. Stoch, S. A.; Wagner, J. A. // Clinical Pharmacology & Therapeutics;Jan2008, Vol. 83 Issue 1, p172 

    Osteoporosis is characterized by low bone mass with skeletal fragility and an increased risk of fracture. This bone loss is brought about by an imbalance between bone resorption and formation. Cathepsin K is the most abundant cysteine protease expressed in the osteoclast and is believed to be...

  • Higher Efficacy of Urinary Bone Resorption Marker Measurements in Assessing Response to Treatment for Osteoporosis in Postmenopausal Women. Abe, Yoshihiro; Ishikawa, Hitoshi; Fukao, Akira // Tohoku Journal of Experimental Medicine;Jan2008, Vol. 214 Issue 1, p51 

    Osteoporosis has reached epidemic proportions. This situation has stimulated the development of biochemical markers to assist in assessing osteoporotic risk and monitoring treatment efficacy. Biochemical markers for assessing the level of bone resorption have been developed during the last few...

  • Can bone turnover markers correlate bone mass at the hip and spine according to menopausal period? Chung, K. W.; Kim, M. R.; Yoo, S. W.; Kwon, D. J.; Lim, Y. T.; Kim, J. H.; Lee, J. W. // Archives of Gynecology & Obstetrics;Nov2000, Vol. 264 Issue 3, p119 

    Changes in bone turnover with years since menopause (YSM) are responsible for bone loss and play a major role in osteoporosis. Although single measurements of the bone turnover marker appear unlikely to be clinically useful in predicting bone mineral density, the usefulness of these measurements...

  • A Meta-analysis of Etidronate for the Treatment of Postmenopausal Osteoporosis. Cranney, A.; Guyatt, G.; Krolicki, N.; Welch, V.; Griffith, L.; Adachi, J. D.; Shea, B.; Tugwell, P.; Wells, G. // Osteoporosis International;Feb2001, Vol. 12 Issue 2, p140 

    : The aim of the study was to review the effect of etidronate on bone density and fractures in postmenopausal women. We searched MEDLINE from 1966 to 1998, examined citations of relevant articles, and the proceedings of international osteoporosis meetings. We contacted osteoporosis investigators...

  • Recognizing and Reporting Vertebral Fractures: Reducing the Risk of Future Osteoporotic Fractures. Lentle, Brian C.; Brown, Jacques P.; Khan, Aliya; Leslie, William D.; Levesque, Jacques; Lyons, David J.; Siminoski, Kerry; Tarulli, Giuseppe; Josse, Robert G.; Hodsman, Anthony // Canadian Association of Radiologists Journal;Feb2007, Vol. 58 Issue 1, p27 

    Objective: Given the increasing evidence that vertebral fractures are underdiagnosed and not acted on, Osteoporosis Canada and the Canadian Association of Radiologists initiated a project to develop and publish a set of recommendations to promote and facilitate the diagnosis and reporting of...

  • c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs. Takasu, Hisashi; Sugita, Atsuko; Uchiyama, Yasushi; Katagiri, Nobuyoshi; Okazaki, Makoto; Ogata, Etsuro; Ikeda, Kyoji // Journal of Clinical Investigation;Feb2006, Vol. 116 Issue 2, p528 

    Although active vitamin D drugs have been used for the treatment of osteoporosis, how the vitamin D receptor (VDR) regulates bone cell function remains largely unknown. Using osteoprotegerin-deficient mice, which exhibit severe osteoporosis due to excessive receptor activator of NF-B...

  • STRETCH YOUR LEGS, SAVE YOUR HIPS.  // Prevention;Mar2006, Vol. 58 Issue 3, p34 

    A report from the International Osteoporosis Foundation shows that women who sit for more than 9 hours a day are 50% more likely to break a hip than those who sit less than 6 hours a day.

  • Protein Palmitoylation Regulates Osteoblast Differentiation through BMP-Induced Osterix Expression. Wai Fook Leong; Tielin Zhou; Gek Liang Lim; Baojie Li // PLoS ONE;2009, Vol. 4 Issue 1, p1 

    Osteoporosis is one of the most common diseases and can be treated by either anti-resorption drugs, anabolic drugs, or both. To search for anabolic drug targets for osteoporosis therapy, it is crucial to understand the biology of bone forming cells, osteoblasts, in terms of their proliferation,...

  • SKULL MONOSTOTIC PAGET'S DISEASE OF BONE -CASE REPORT AND REVIEW OF THE LITERATURE. Poiana, Catalina; Carsote, Mara; Hortopan, D.; Coculescu, M. // Acta Endocrinologica (1841-0987);Jul-Sep2007, Vol. 3 Issue 3, p333 

    Paget's disease of bone is a metabolic skeleton disorder with different epidemiological patterns: increased incidence up to 3% of the Northern Caucasian population over the age of 55 or a very rare occurrence as in Asia. We present a case of a 69 years old female patient with diffuse bone pain,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics